Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Psychopharmacology (Oxford, England)|June 18, 2025
Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis timesMaria Bălăeţ, William Trender, Annalaura Lerede, et al.Brain Communications|August 22, 2023
Patient-reported outcomes in multiple sclerosis: a prospective registry cohort studyAnnalaura Lerede, Jeff Rodgers, Rod M Middleton, et al.NPJ Digital Medicine|November 20, 2024
An iterative approach for estimating domain-specific cognitive abilities from large scale online cognitive dataValentina Giunchiglia, Dragos-Cristian Gruia, Annalaura Lerede, et al.Frontiers in Psychology|August 4, 2023
Mapping the sociodemographic distribution and self-reported justifications for non-compliance with COVID-19 guidelines in the United KingdomMaria Bălăeț, Danielle L Kurtin, Dragos C Gruia, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 22, 2024
Identifying definite patterns of unmet needs in patients with multiple sclerosis using unsupervised machine learningElisabetta Maida, Gianmarco Abbadessa, Eleonora Cocco, et al.NPJ Digital Medicine|May 7, 2024
Online cognitive monitoring technology for people with Parkinson's disease and REM sleep behavioural disorderMaria Bălăeţ, Falah Alhajraf, Tanja Zerenner, et al.Nature Communications|September 3, 2025
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairmentAnnalaura Lerede, Alexandra Moura, Valentina Giunchiglia, et al.Nutrients|November 13, 2025
Mediterranean and MIND Dietary Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis RegisterMaggie Yu, Steve Simpson-Yap, Annalaura Lerede, et al.Therapeutic Advances in Neurological Disorders|September 29, 2023
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across EuropeRichard Nicholas, Jeff Rodgers, James Witts, et al.Pageof 1